New mRNA cancer vaccine shows strong tumor regression in early human trial, spurring biotech rally
A groundbreaking mRNA cancer vaccine has demonstrated strong tumor regression in an early-stage human trial. This promising result has fueled a surge in biotech stocks. The trial findings have captured…
